Latest Breaking News On - Board of biohaven pharmaceuticals - Page 1 : comparemela.com

/PRNewswire/ Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Nurtec® ODT (rimegepant) extends its sponsorship for the second year as the primary.

Pearl harborUnited statesNorth carolinaKate fegleyGreg petermanTakuma satoMike beyerBiohaven neuroinnovationCenters for diseaseExchange commission onWorld health organizationDrug administrationSam brown incBiohaven supports military salutes programBiohaven pharmaceutical holding company ltdSalutes program